Effects of LY294002,a Specific Inhibitor of Phosphatidylinositol 3 Kinase,on Cardiomyocytes Subject to Ischemia and Hypoxia

SONG Hua-pei,YAN Hong,DANG Yong-ming,CHU Zhi-gang,ZHANG Qiong,HUANG Yue-sheng
DOI: https://doi.org/10.3969/j.issn.1673-6273.2007.11.019
2007-01-01
Abstract:Objective:To clarify the effects of PI3K/Akt pathway on cardiomyocytes subjected to ischemia and hypoxia.Methods: Cardiomyocytes were cultured in vitro.Viabilities of cardiomyocytes,lactate dehydrogenase(LDH)leaking and ratio of propidium io- dide(PI)staining positive cells were observed to test the effects of LY294002,a specific inhibitor of phosphatidylinositol 3-kinase,when exposed to stimulation of isehemia and hypoxia.Results:Viabilities of cardiomyocytes subjected to ischemia and hypoxia by the inhibi- tion of PI3K/Akt pathway were significantly lower and LDH leak-age and ratio of PI staining positive cells were significantly higher than those without PI3K/Akt pathway inhibition(P<0.01 ).Conclusion:LY294002 can aggravate the injury of cardiomyocytes subjected to is- ehemia and hypoxia,which suggests that the PI3K/Akt pathway can protect cardiomyocytes from injury of ischemia and hypoxia.
What problem does this paper attempt to address?